Gainers
- Aclaris Therapeutics, Inc. ACRS stock moved upwards by 70.9% to $1.88 during Tuesday's pre-market session. According to the most recent rating by JMP Securities, on September 06, the current rating is at Market Perform.
- Capricor Therapeutics, Inc. CAPR shares surged 28.3% to $3.49. The most recent rating by H.C. Wainwright, on July 15, is at Buy, with a price target of $12.40.
- Tonix Pharmaceuticals, Inc. TNXP shares moved upwards by 8.8% to $0.52.
- Novo Nordisk, Inc. NVO stock increased by 2.7% to $50.80. According to the most recent rating by Citigroup, on September 17, the current rating is at Buy.
- AstraZeneca, Inc. AZN stock moved upwards by 2.1% to $43.40.
- Teva Pharmaceutical Indus, Inc. TEVA shares increased by 1.2% to $8.13. The market cap stands at $7.3 billion. According to the most recent rating by Guggenheim, on September 12, the current rating is at Neutral.
- Novartis, Inc. NVS stock moved upwards by 1.1% to $87.10.
Losers
- Sienna Biopharmaceuticals, Inc. SNNA stock declined 36.1% to $0.43 during Tuesday's pre-market session. The market cap seems to be at $346.5 million. The most recent rating by BMO Capital, on September 05, is at Outperform, with a price target of $3.00.
- Aurora Cannabis, Inc. ACB stock decreased by 1.3% to $5.38. The market cap seems to be at $6.3 billion. The most recent rating by Stifel, on September 16, is at Sell, with a price target of $5.00.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in